Wnt signaling in pancreatic islets

Area of Science:

• Endocrinology
• Molecular Biology
• Genetics

Background:

• The Wnt signaling pathway is crucial for cellular processes including stem cell regulation, organogenesis, and body plan development.
• Canonical Wnt signaling, mediated by beta-catenin/TCF7L2, plays a vital role in pancreas development, islet cell function, and insulin secretion.
• Hormones like glucagon-like peptide-1 and chemokines such as stromal cell-derived factor-1 influence Wnt signaling in beta-cells, impacting their growth and survival.

Purpose of the Study:

• To review the hormonal regulation of Wnt signaling within pancreatic islets.
• To explore the implications of Wnt signaling pathway mutations in the context of type 2 diabetes risk alleles.
• To highlight the fundamental role of TCF7L2 in both Wnt signaling and beta-cell function.

Main Methods:

• Review of existing literature on Wnt signaling, beta-cell function, and type 2 diabetes genetics.
• Analysis of genome-wide association studies (GWAS) identifying diabetes susceptibility loci.
• Examination of experimental data on TCF7L2 function in islets and human TCF7L2 polymorphisms.

Main Results:

• Genome-wide association studies identified 19 gene loci associated with type 2 diabetes risk, with 14 encoding proteins involved in islet growth and function.
• Seven of these diabetes risk loci involve Wnt signaling components or targets.
• TCF7L2 is strongly linked to diabetes risk, and its disruption impairs glucose-stimulated insulin secretion.

Conclusions:

• Perturbations in the Wnt signaling pathway significantly contribute to type 2 diabetes susceptibility and pathogenesis.
• Mutations in Wnt signaling pathway components represent a source of risk-associated alleles for type 2 diabetes.
• Understanding Wnt signaling in islets is critical for unraveling the mechanisms underlying type 2 diabetes.